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In 1976 and 1984, cattle and buffalo in northwestern India experienced major outbreaks of foot-and-mouth disease (FMD) due to type Asia 1. Normally, FMD virus (FMDV) type O is predominant in this region. 11 Outbreaks of disease caused by FMDV Asia 1 show periods of low incidence and then major reemergence. Mechanisms of persistence of FMDV in ruminants remain unclear. The primary site for FMDV replication and persistence is the oropharyngeal area. 3 Thus, from an epizootiologic point of view, neutralizing activity against FMDV in buccal secretions of ruminants is of special interest. In this study, neutralizing activity against FMDV type Asia 1 in nasal and buccal secretions of calves was measured after vaccination and/or infection with FMDV type Asia 1.
Fourteen calves, 6-8 months old, were kept in an isolation facility. The calves were dewormed with fenbendazole a and sprayed with malathion, and their peripheral blood smears were screened for hemoprotozoa. Esophageal-pharyngeal fluids were tested for persistent FMDV. 12 Calves were randomly divided into 4 groups (3-4 calves/ group). Each calf in groups I and III was vaccinated with monovalent FMDV Asia 1 vaccine. Secretions were collected 0, 14, 21, and 28 days after vaccination. After 21 days, vaccinated calves in group I and unvaccinated calves in group II were challenged with 10,000 TCID 50 of FMDV Asia 1 by the intradermolingual route, and secretions were collected 7, 14, and 21 days postchallenge. Calves in group IV were unvaccinated, uninfected controls.
The seed stock of FMDV Asia l b was passaged 4 times in baby hamster kidney-21 cell line and stored at -20 C.
The calves were vaccinated with tissue-culture-propagated formalin-and heat-inactivated aluminum-hydroxide-adsorbed FMDV Asia I vaccine c (2.5 ml/calf).
Before collection of secretions (nasal and oral), the calves were kept off feed overnight and were only offered drinking water. Secretions were collected from these calves by methods previously described. 7 Secretions were centrifuged at 5,000 rpm for 20 minutes to sediment any feed particles. The samples were inactivated at 56 C for 30 minutes and dialyzed against isotonic saline (100 times the volume of the sample) for 18 hours at 4 C. Before testing, all the samples were checked for contamination with blood by Adler's benzidine base test for hemoglobin. The samples were stored at -20 C.
A neutralization test was performed using constant virus and varying secretion method. Serial dilutions of the samples were prepared in phosphate-buffered saline (pH 7.2) containing penicillin (1,000 IU/ml) and streptomycin (500 µg/ ml). An equal volume of virus dilution was added to each sample dilution to give a final virus concentration of 100 MLD 50 (mouse lethal dose). The virus-sample mixture was incubated at 37 C for 30 minutes and inoculated intraperitoneally into suckling mice (50 µl/mouse). Neutralization titers were calculated by the Reed-Muench formula and expressed as the log,, of the reciprocal of the sample dilution protecting 50% of the mice inoculated with the sample-virus mixture.
10 Neutralization titers in pooled secretion samples (3-4 calves) are shown in Fig. 1 .
In uninfected, unvaccinated control calves, secretions (nasal and esophageal-pharyngeal fluid) showed no neutralizing activity. However, the saliva had a titer of log 10 0.8-1.2. The neutralizing factor present in normal saliva has not been completely characterized. It is dialyzable, heat labile at 70 C, insensitive to sodium azide, insensitive to mercuric chloride, and insensitive to iodo acetamide. 2 After vaccination, calves developed neutralizing activity against FMDV in the secretions. However, another research group failed to observe neutralizing activity up to 30 days after vaccination with an inactivated vaccine by subcutaneous or nasopharyngeal route. 4 Reason for the failure to observe neutralizing activity in their study may be the diluted nasal secretions (total protein, 2 mg/ml) used, as compared with those of our study (total protein, 10 mg/ml). We observed neutralizing activity in nasal secretions collected 45 days postvaccination (log,, 1.05) and 60 days postvaccination (log 10 0.6).
Among the 4 groups of calves, the unvaccinated challenged group developed higher neutralizing activity than did vaccinated-challenged and vaccinated groups ( Fig. 1 ).
Among the 3 secretions, saliva had the highest neutralizing activity, followed by esophageal-pharyngeal fluid and nasal secretions.
In our study, neutralizing activity was higher than that reported in European cattle for FMDV types O, A, and C. This higher activity could be due to differences in host genotype, in type of FMDV used, or in assay systems (in vivo mouse protection test vs. in vitro virus neutralization test in cell culture). Bos indicus responds better to keyhole limpet hemocyanin than does Bos taurus at the mucosal surfaces. 1 Neutralization titers in our study did not correlate with immunoglobulin levels measured by single radial immunodiffusion (data not shown). 8 Secretions tested by the mouse bioassay system showed with serum neutralizing antibody. 5, 6, 9 The inability of the antibodies in serum to neutralize the entire population of FMDV is due to presence of 2 types of FMDV-specific antibodies: 140S reactive antibodies that neutralize FMDV effectively and a mixture of 140S and 12S reactive antibodies that do not neutralize FMDV effectively. 5 The antibodies reactive to 12S block the specific neutralization by stearic hindrance through binding at the noncritical, nonneutralizing sites of FMDV. FMDV in the vaccine was inactivated by heat, and this treatment breaks the virus into 12S particles. Thus, the vaccinated calves may have developed antibodies to 12S particles. The vaccine was, however, clinically effective; vaccinated challenged calves did not develop viremia or foot lesions, whereas the unvaccinated challenged calves developed both viremia and foot lesions. Moreover, the unvaccinated challenged calves developed a higher (1-2 F) thermal response (fever) than did vaccinated challenged calves.
This study indicates that formation of nonneutralized virus, as observed in vitro, may be the mechanism of FMDV carrier status in vivo. In the esophageal region, nonneutralizing antibodies may complex with FMDV but fail to neutralize it. These viruses are subdivided into 6 antigenically distinct groups, designated A-F, 6,7 with members in a group sharing a common antigen or antigens. Most rotaviruses detected in clinical specimens belong to group A. For example, group A rotaviruses are ubiquitous agents of diarrhea in calves, children, and piglets, whereas non-group A rotaviruses are only sporadically detected in these species. 1, 8, 9 Ovine rotaviruses, in Other signs included weight loss, lethargy, and. mild dehydration. Morbidity was approximately 75% (out of 369 confinement-reared lambs), but there was no mortality. Diarrheic lambs were treated with oral antibiotics (sulfamethoxazole/trimethoprim a ) and electrolytes as needed. A separate group of lambs born on open location during April and May did not pasture at experience the same diarrhea. During the following were not observed in lambs fall lambing season, diarrheic the confinement facility. contrast to the globally distributed rotaviruses infecting other Fecal specimens were collected from 6 confinement-reared livestock, have been reported only in the United Kingdom lambs (5 with diarrhea and 1 without) in mid-April and held and Japan. 2, 4, 5, 10 Moreover, rotaviruses recovered from lambs at 4 C throughout. A portion of each specimen was processed are often non-group A rotaviruses. 2, 3, 9 This report on group for cell culture immunofluorescent assay (CCIF) as described B rotavirus from diarrheic lambs in Ohio is the first on ovine previously 13 and then stored at 4 C until tested. The CCIF rotavirus in the United States.
for group A rotavirus using MA104 rhesus monkey kidney An outbreak of acute, self-limiting diarrhea occurred in 2-cell monolayers was performed as previously described. 13 14-day-old suckling lambs born and raised in an intensive Furthermore, aliquots of processed specimens were tested confinement facility at the Ohio Agricultural Research and for group B rotavirus by CCIF after centrifugation onto Development Center (OARDC) in Wooster; these lambs were MA104 cell monolayers as described previously. 15 the progeny of primiparous and multiparous ewes in a flock Another portion of each of the 5 fecal specimens was prothat had been closed for the preceding 2 years. The outbreak cessed for immune electron microscopy (IEM) as described began in February 1993, about 2 weeks after the spring lambing season started, and continued until the, end of April, at which time spring confinement lambing had ceased. The local weather, including average air temperature, wind speed, and precipitation, was normal during this time, as compared with long-term averages established by the Wooster Weather Station at the OARDC. Affected lambs were diarrheic for 26 pre viously. 14 Insufficient quantity of 1 fecal specimen (lamb no. 5) precluded its processing for IEM, so an aliquot of the CCIF-processed specimen was used instead. IEM for group A rotavirus was performed by mixing 75 µl of processed specimen with 300 µl diluted group A rotavirus antiserum overnight at 4 C; this antiserum was derived from a gnotobiotic pig hyperimmunized with porcine group A rotavirus 72 hours and voided yellow, semiliquid, malodorous stools. (OSU isolate). 12 used; this antiserum was derived from a gnotobiotic pig hy-
